Search Hotels in Sausalito

Famed Investor Michael Burry Bets Against Nvidia and Palantir to the Tune of $1.1 billion. Is He Right? ↗

November 06, 2025

Burry is famous for shorting the market during the mortgage crisis. Is he going to win big again?

A groundbreaking $2 million grant from the National Institutes of Health (NIH) is set to dramatically accelerate advancements in gene-editing technology, with artificial intelligence (AI) emerging as...

Topics Artificial Intelligence

AI Unlocks Gene-Editing Revolution: $2 Million Grant Propels Disease Cures

November 06, 2025

Via TokenRing AI

Topics Artificial Intelligence Climate Change Intellectual Property

Eli Lilly, Novo Nordisk Make Weight-Loss Drugs More Affordable Via Medicare, Medicaid, TrumpRx ↗

November 06, 2025

The Trump administration struck deals with Eli Lilly and Novo Nordisk to lower obesity drug prices and expand Medicare coverage starting in 2026.

Via Benzinga

Topics Government

Stay informed about the most active stocks in the S&P500 index on Thursday's session. ↗

November 06, 2025

Stay informed about the most active S&P500 stocks in today's session as we take a closer look at what's happening on the US markets on Thursday. Discover the stocks that are generating the highest...

Via Chartmill

3 Value Stocks That Fall Short

November 06, 2025

Value stocks typically trade at discounts to the broader market, offering patient investors the opportunity to buy businesses when they’re out of favor. The key risk, however, is that these stocks are...

Via StockStory

Pfizer To Raise Metsera Bid After Court Denies Attempt To Block Rival Deal ↗

November 06, 2025

Delaware court denies Pfizer bid to block Metsera's Novo Nordisk deal as FTC flags antitrust risks and Pfizer prepares a higher counteroffer.

Via Benzinga

Eli Lilly And Novo Nordisk Ignite Bullish Retail Frenzy Ahead Of TrumpRx Deals To Slash Prices For Weight-Loss Drugs ↗

November 04, 2025

Novo Nordisk Reportedly Refrains From Backing Down In Metsera Acquisition Battle, Sweetens Bid Further ↗

November 06, 2025

According to an FT report, Pfizer now has two days to match Novo’s new bid or let its agreed-upon deal with Metsera fall through.

San Diego, CA – November 6, 2025 – Ligand Pharmaceuticals (NASDAQ: LGND) has recently captured the financial spotlight, with its stock hitting a remarkable 52-week high of $197.78 on November 6, 2025....

Ligand Pharmaceuticals Soars to New Heights: A Deep Dive into its 52-Week High

November 06, 2025

'It's Getting Ugly,' Analyst Says As Pfizer Escalates Its Gloves-Off Fight For Metsera ↗

Topics Intellectual Property

November 06, 2025

Metsera stock surged Thursday on reports Pfizer has matched Novo Nordisk's $10 billion bid to buy the obesity-focused biotech.

Via Investor's Business Daily

Market Momentum Stalls: Valuations Under Scrutiny as Bullish Run Faces Headwinds

November 06, 2025

As November 2025 unfolds, the global stock markets find themselves at a critical juncture, struggling to reclaim the robust bullish momentum that characterized much of the preceding years. A palpable...

Medication company Viatris (NASDAQ:VTRS) beat Wall Street’s revenue expectations in Q3 CY2025, but sales were flat year on year at $3.76 billion. The company’s full-year revenue guidance of $14.1...

Topics Artificial Intelligence Economy World Trade

Viatris’s (NASDAQ:VTRS) Q3 Sales Top Estimates

November 06, 2025

Via StockStory

Why Pfizer's 7%-Yielding Dividend Just Became Safer -- and More Tempting ↗

November 06, 2025

Pfizer just gave income investors four reasons to like its juicy dividend even more.

With big yields, these turnaround stocks look like they are attractively priced for those who can handle some uncertainty.

Topics Earnings Intellectual Property

2 Dirt Cheap Stocks to Buy With $1,000 Right Now ↗

November 06, 2025

Novo Nordisk Snaps 11-Day Losing Streak After Court Rejects Pfizer’s Challenge To $10B Metsera Deal ↗

November 05, 2025

Delaware Chancery Judge Morgan Zurn ruled that Pfizer’s objections did not justify delaying Novo’s $10 billion acquisition of obesity-drug startup Metsera.

The United States economy is currently riding a wave of positive momentum, with a series of robust economic indicators signaling underlying strength and resilience. This optimistic outlook has, in...

Topics Law Enforcement

US Economic Resilience Fuels Dollar's Ascent Amidst Global Shifts

November 05, 2025

The financial markets, still reeling from a tumultuous period marked by significant downturns, are now grappling with an uneasy attempt at consolidation. As of November 5, 2025, investors are...

Topics Artificial Intelligence Bonds Economy

Pfizer Responds to Delaware Chancery Court Ruling

November 05, 2025

From Pfizer Inc.

Via Business Wire

Navigating the Tempest: Market Consolidation Amidst Post-Slide Uncertainty

November 05, 2025

The burgeoning market for obesity and diabetes treatments, particularly GLP-1 receptor agonists, is witnessing a dramatic divergence in fortunes among its leading players. As of November 5, 2025, Novo...

Topics Artificial Intelligence Bonds Economy

Obesity Drugmakers Face Shifting Tides: Novo Nordisk Plunges While Eli Lilly Soars

November 05, 2025

US Government Shutdown Casts a Shadow: Data Blackout and Market Jitters as Longest Shutdown Unfolds

Topics Economy

November 05, 2025

The United States finds itself in an unprecedented economic fog as a prolonged government shutdown, now stretching well into its second month, has brought the flow of critical official data to a...

Stay informed about the most active S&P500 stocks in today's session as we take a closer look at what's happening on the US markets on Wednesday. Discover the stocks that are generating the highest...

Topics Economy

These S&P500 stocks are the most active in today's session ↗

November 05, 2025

Via Chartmill

10 Health Care Stocks Whale Activity In Today's Session ↗

November 05, 2025

Via Benzinga

AI Achieves Atomic Precision in Antibody Design: A New Era for Drug Discovery Dawns

November 05, 2025

Seattle, WA – November 5, 2025 – In a monumental leap for biotechnology and artificial intelligence, Nobel Laureate David Baker’s lab at the University of Washington’s Institute for Protein Design...

Via TokenRing AI

Topics Artificial Intelligence Intellectual Property

Here's Why Shares in Viking Therapeutics Shot Higher in October ↗

November 05, 2025

Three factors took Viking's shares higher in the month.

3 Magnificent Ultra-High-Yield Dividend Stocks -- Sporting an Average Yield of 8.5% -- to Buy With Confidence in November ↗

November 05, 2025

These supercharged income stocks have the necessary catalysts to pad the pocketbooks of patient investors.

U.S. Government Shutdown Plunges Nation into Uncharted Economic Waters: Longest in History Deepens Market Uncertainty

November 05, 2025

Washington D.C., November 5, 2025 – The United States is grappling with an unprecedented fiscal crisis, as an ongoing government shutdown, now in its 36th day, has officially become the longest in the...

Can Novo Nordisk’s ‘Attractive’ Fundamentals Outweigh Slowing Wegovy Sales And A $149 Price Cap? ↗

Topics Bonds Economy Government

November 05, 2025

Novo Nordisk cut its 2025 profit and sales forecasts as slower GLP-1 growth and pricing pressure hit margins.

Global pharmaceutical company Pfizer (NYSE:PFE) met Wall Streets revenue expectations in Q3 CY2025, but sales fell by 5.9% year on year to $16.65 billion. On the other hand, the company’s full-year...

Topics Lawsuit

PFE Q3 Deep Dive: Pipeline, Cost Controls, and Business Development Shape Outlook

November 05, 2025

Via StockStory

U.S. PMI Data Looms: A Pivotal Moment for the Dollar and Global Markets

November 04, 2025

The financial world is holding its breath as the release of the upcoming U.S. Purchasing Managers' Index (PMI) data draws near. This crucial economic indicator is not merely a snapshot of business...